Yoshida S, Todoroki T, Koike N, Maruyama T, Kawamoto T, Fukao K, Shimizu W, Ohara K, Monoi H, Yamamoto Y, Kawai Y
Dept. of Surgery, University of Tsukuba.
Gan To Kagaku Ryoho. 1999 Aug;26(9):1343-7.
Three cases of prominent-type advanced esophageal cancer were treated with chemoradiation therapy using a 5-FU analog and low dose CDDP. All cases showed a complete response after the treatment. Only mild bone marrow suppression was found in one case. This protocol will be applied for patients with prominent-type advanced esophageal cancers, especially high risk patients.